Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Dividend Stocks That Are Worth Your Money

By Chris Lau, InvestorPlace Contributor

Income investors have plenty of dividend stocks to choose from, but not all of them are investment worthy.

Amazon Stock Is Poised to Offer Another 20% Upside

By Chris Lau, InvestorPlace Contributor

Amazon.com is offering another type of credit card to customers and Amazon stock will benefit in the end. Every little bit helps.

Nvidia Stock Is Set to Rebound as Investors Look Past Near-Term Pains

By Chris Lau, InvestorPlace Contributor

Markets are still upset over Nvidia's uncertainties for the year. Still, the ong-term growth prospects for NVDA stock are bright.

Why Bank of America Stock Looks Set To Retake The $30 Level

By Chris Lau, InvestorPlace Contributor

Bank of America would have traded in the $30s but recent market selling stopped that. Now, with markets rebounding, BAC stock may get there.

Here’s Why Beat-Down Tilray Stock Could Keep Dropping To As Low As $30

By Chris Lau, InvestorPlace Contributor

Less than a year ago, Tilray (NASDAQ:TLRY) traded at an eye-popping $300 a share. But Sept. 19 is a long time ago in the cannabis…

Load More